摘要
目的探析实时荧光定量聚合酶链式反应(FQ-PCR)联合酶联免疫吸附试验(ELISA)在乙型肝炎检测中的临床价值。方法180例乙型肝炎患者,根据检测方法不同分为对照1组(59例)、对照2组(59例)及观察组(62例)。对照1组行FQ-PCR检测,对照2组行ELISA检测,观察组行FQ-PCR+ELISA检测。对比三组检测结果。结果观察组诊断乙型肝炎的准确率为96.77%,对照1组诊断乙型肝炎的准确率为84.75%,对照2组诊断乙型肝炎的准确率为81.36%。观察组诊断乙型肝炎的准确率明显高于对照1组与对照2组,差异具有统计学意义(P<0.05)。对照1组与对照2组诊断乙型肝炎的准确率比较,差异无统计学意义(P>0.05)。结论相对于单一检测手段,FQ-PCR联合ELISA在乙型肝炎检测时诊断准确率更高,可为临床治疗提供准确依据,具有临床应用价值。
Objective To discuss the clinical value of fluorescence quantitative polymerase chain reaction(FQ-PCR)combined with enzyme-linked immunosorbent assay(ELISA)in hepatitis B.Methods A total of 180 patients with hepatitis B were divided into control group 1(59 cases),control group 2(59 cases)and observation group(62 cases)according to different detection methods.Control group 1 underwent FQ-PCR detection,control group 2 underwent ELISA detection,and observation group underwent FQ-PCR+ELISA detection.The test results of the three groups were compared.Results The diagnostic accuracy of hepatitis B in the observation group was 96.77%,that in the control group 1 was 84.75%,and that in the control group 2 was 81.36%.The diagnostic accuracy of hepatitis B in the observation group was significantly higher than that in the control group 1 and the control group 2,and the difference was statistically significant(P<0.05).There was no statistically significant difference in the diagnostic accuracy of hepatitis B between control group 1 and control group 2(P>0.05).Conclusion Compared with single detection method,FQ-PCR combined with ELISA has higher diagnostic accuracy in hepatitis B,which can provide accurate basis for clinical treatment and has clinical application value.
作者
林爽
LIN Shuang(Department of Clinical Laboratory,Chifeng Hospital,Chifeng 024000,China)
出处
《中国实用医药》
2022年第8期93-95,共3页
China Practical Medicine
关键词
酶联免疫吸附试验
实时荧光定量聚合酶链式反应
乙型肝炎
Enzyme-linked immunosorbent assay
Fluorescence quantitative polymerase chain reaction
Hepatitis B